Study title: "Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study. SW Boellner, et al., Current Medical Research and Opinion 2006, 22(12): 2457-65. "
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Nervous System Diseases | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: MODAFINIL | |||||
ATC code: | |||||
Document link: EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls | |||||
Document date: 2011-09-19 | |||||
Study number: C1538a/213/AD/US/OL | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |